One in two men and one in three women will develop cancer in their lifetime. Overall, cancer is the second leading cause of death (behind heart disease) in both the United States and in New Jersey. Despite declines over time in certain cancers within the state, New Jersey continues to rank among the top ten worst states in cancer incidence. Among the more than 50,000 new cases diagnosed annually, common screening-detectable cancers — such as breast, prostate, colorectal and lung cancers — account for nearly half of all new cases among both men and women in New Jersey.
In partnership with the Rutgers Cancer Institute of New Jersey, the New Jersey Department of Health, and healthcare and community organizations across New Jersey, ScreenNJ aims to increase screening for breast, cervical, colorectal, genetically-linked, HPV-linked, lung, prostate, and skin cancers to reduce cancer mortality rates, to reduce disparities, and to educate New Jersey residents about the importance of cancer screening, early detection, and prevention.
ScreenNJ partners with, connects, and supports healthcare provider agencies, public health agencies, and community organizations throughout the state that provide education on, refer patients to, or directly provide screening services for cancer. ScreenNJ also helps organizations initiate or expand these types of outcomes-oriented, evidence-based screening and outreach services.
The goals of ScreenNJ are to:
- increase access to timely cancer screening,
- reduce cancer mortality rates,
- reduce disparities in cancer screening access, and
- educate New Jersey residents about the importance of cancer screening, early detection, and prevention
Please visit our partner page to learn more about how you can join us in our efforts!